Abstract
Prognostic models for disease occurrence, tumor progression and survival are abundant for most types of cancers. Physicians and cancer patients are utilizing these models to make informed treatment decisions and corresponding arrangements. However, not all cancer prognostic models are built and validated rigorously. Some are more useful and reliable than others. In this chapter, we briefly introduce some popular machine learning methods for constructing cancer prognostic models, and discuss pros and cons of each. We also introduce the commonly used discrimination and calibration metrics for assessing predictive performance and validating the prognostic models. In the end, we outline several challenges of using prognostic models in the real world for clinical decision-making support, and propose related suggestions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmad A. Pathways to breast cancer recurrence. ISRN Oncol. 2013;2013:290568. doi:10.1155/2013/290568.
Ahmad LG, Eshlaghy AT, Poorebrahimi A, et al. Using three machine learning techniques for predicting breast cancer recurrence. J Heal Med Inform. 2013;4:1000124. doi:10.4172/2157-7420.1000124.
Altman DG, Royston P. What do we mean by validating a prognistic model? Stat Med. 2000;19:453–73.
Ankerst DP, Hoefler J, Bock S, et al. Prostate cancer prevention trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. Urology. 2014;83:1362–7. doi:10.1016/j.urology.2014.02.035.
Bellaachia A, Guven E. Predicting breast cancer survivability using data mining techniques. SIAM Int Conf Data Min. 2006;6:1–4. doi:10.1109/ICSTE.2010.5608818.
Bharathi A, Natarajan AM. Cancer classification using support vector machines and relevance vector machine based on analysis of variance features. J Comput Sci. 2011;7:1393–9.
De Bin R, Sauerbrei W, Boulesteix A-L. Investigating the prediction ability of survival models based on both clinical and omics data: Two case studies. Stat Med. 2014;33:5310–29. doi:10.1002/sim.6246.
Boser BE, Guyon IM, Vapnik VN. A training algorithm for optimal margin classifiers. In: Proceedings of the 5th annual ACM workshop on computational learning theory. New York: ACM Press; 1992. p. 144–152.
Bottaci L, Drew PJ, Hartley JE, et al. Artificial neural networks applied to outcome prediction for colorectal cancer patients in separate institutions. Lancet. 1997;350:469–72. doi:10.1016/S0140-6736(96)11196-X.
Bou-Hamd I, Larocque D, Ben-Ameur H. A review of survival trees. Stat Surv. 2011;5:44–71. doi:10.1214/09-SS047.
Boulesteix A, Sauerbrei W. Added predictive value of high-throughput molecular data to clinical data and its validation. Brief Bioinform. 2011;12:215–29. doi:10.1093/bib/bbq085.
Burges CJC. A tutorial on support vector machines for pattern recognition. Data Min Knowl Discov. 1998;2:121–67.
Burke HB, Goodman PH, Rosen DB, et al. Artificial neural networks improve the accuracy of cancer survival prediction. Cancer. 1997;79:857–62.
Chow E, Abdolell M, Panzarella T, et al. Predictive model for survival in patients with advanced cancer. J Clin Oncol. 2008;26:5863–9. doi:10.1200/JCO.2008.17.1363.
Chow E, James JL, Hartsell W, et al. Validation of a predictive model for survival in patients with advanced cancer: Secondary analysis of RTOG 9714. World J Oncol. 2011;2:181–90. doi:10.4021/wjon325w.
Clark GM. Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib. Mol Oncol. 2008;1:406–12. doi:10.1016/j.molonc.2007.12.001.
Craven MW, Shavlik JW. Extracting tree-structured representations of trained networks. In: Advances in neural information processing systems. Denver: MIT Press; 1996. p. 24–30.
Delen D, Walker G, Kadam A. Predicting breast cancer survivability: A comparison of three data mining methods. Artif Intell Med. 2005;34:113–27. doi:10.1016/j.artmed.2004.07.002.
Dettling M, Bühlmann P. Boosting for tumor classification with gene expression data. Bioinformatics. 2003;19:1061–9. doi:10.1093/bioinformatics/btf867.
Faraggi D, LeBlanc M, Crowley J. Understanding neural networks using regression trees: an application to multiple myeloma survival data. Stat Med. 2001;20:2965–76. doi:10.1002/sim.912.
Freund Y, Schapire RE. A desicion-theoretic generalization of on-line learning and an application to boosting. J Comput Syst Sci. 1997;55:119–39. doi:10.1006/jcss.1997.1504.
Friedman JH, Meulman JJ. Multiple additive regression trees with application in epidemiology. Stat Med. 2003;22:1365–81. doi:10.1002/sim.1501.
Furey TS, Cristianini N, Duffy N, et al. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics. 2000;16:906–14.
Ganesan N, Vankatesh K, Rama MA, Palani AM. Application of neural networks in diagnosing cancer disease using demographic data. Int J Comput Appl. 2010;1:76–85. doi:10.5120/476-783.
Garson DG. Interpreting neural-network connection weights. Artif Intell Expert. 1991;6:46–51.
Ge G, Wong GW. Classification of premalignant pancreatic cancer mass-spectrometry data using decision tree ensembles. BMC Bioinform. 2008;9:275. doi:10.1186/1471-2105-9-275.
Glare P. Clinical predictors of survival in advanced cancer. J Support Oncol. 2005;3:331–9.
Goh ATC. Back-propagation neural networks for modeling complex systems. Artif Intell Eng. 1995;9:143–51. doi:10.1016/0954-1810(94)00011-S.
Goldberg Y, Kosorok MR. Support vector regression for right censored data. 2012. arXiv 1202.5130v2.
Graf E, Schmoor C, Sauerbrei W, Schumacher M. Assessment and comparison of prognostic classification schemes for survival data. Stat Med. 1999;18:2529–45. doi:10.1002/(SICI)1097-0258(19990915/30)18:17/18<2529:AID-SIM274>3.0.CO;2-5.
Gupta S, Tran T, Luo W, et al. Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry. BMJ Open. 2014;4:e004007. doi:10.1136/bmjopen-2013-004007.
Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using support vector machines. Mach Learn. 2002;46:389–422.
Halabi S, Lin C-Y, Kelly WK, et al. Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer. J Clin Oncol. 2014;32:671–7. doi:10.1200/JCO.2013.52.3696.
Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–87.
Henderson R, Jones M, Stare J. Accuracy of point predictions in survival analysis. Stat Med. 2001;20:3083–96. doi:10.1002/sim.913.
Henderson R, Keiding N. Individual survival time prediction using statistical models. J Med Ethics. 2005;31:703–6. doi:10.1136/jme.2005.012427.
Hofner B, Boccuto L, Göker M. Controlling false discoveries in high-dimensional situations: boosting with stability selection. BMC Bioinform. 2015;16:144. doi:10.1186/s12859-015-0575-3.
Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed. New York: Wiley Interscience; 2013.
Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008;2:841–60. doi:10.1214/08-AOAS169.
Jonsdottir T, Hvannberg ET, Sigurdsson H, Sigurdsson S. The feasibility of constructing a predictive outcome model for breast cancer using the tools of data mining. Expert Syst Appl. 2008;34:108–18. doi:10.1016/j.eswa.2006.08.029.
Kass GV. An exploratory technique for investigating large quantities of categorical data. Appl Stat. 1980;29:119–27. doi:10.2307/2986296.
Katz MHG, Hu C-Y, Fleming JB, et al. A clinical calculator of conditional survival estimates for resected and unresected pancreatic cancer survivors. Arch Surg. 2012;147:513–9. doi:10.1001/archsurg.2011.2281.
Khan FM, Zubek VB. Support vector regression for censored data (SVRc): a novel tool for survival analysis. In: Eighth IEEE international conference on data mining. New York: IEEE; 2008. p. 863–868.
Kharya S. Using data mining techniques for diagnosis and prognosis of cancer disease. Int J Comput Sci Inf Technol. 2012;2:55–66. doi:10.5121/ijcseit.2012.2206.
Laber EB, Zhao YQ. Tree-based methods for individualized treatment regimes. Biometrika. 2015;102:501–14. doi:10.1093/biomet/asv028.
Lancashire LJ, Lemetre C, Ball GR. An introduction to artificial neural networks in bioinformatics—application to complex microarray and mass spectrometry datasets in cancer studies. Brief Bioinform. 2009;10:315–29. doi:10.1093/bib/bbp012.
LeBlanc M, Crowley J. Relative risk tees for censored survival data. Biometrics. 1992;48:411–25.
LeBlanc M, Kooperberg C. Boosting predictions of treatment success. Proc Natl Acad Sci USA. 2010;107:13559–60. doi:10.1073/pnas.1008052107.
Lisboa PJ, Taktak AFG. The use of artificial neural networks in decision support in cancer: a systematic review. Neural Netw. 2006;19:408–15. doi:10.1016/j.neunet.2005.10.007.
Liu HX, Zhang RS, Luan F, et al. Diagnosing breast cancer based on support vector machines. J Chem Inf Comput Sci. 2003;43:900–7.
Loh W-Y. Classification and regression trees. Wiley Interdiscip Rev Data Min Knowl Discov. 2011;1:14–23. doi:10.1002/widm.8.
Louie KS, Seigneurin A, Cathcart P, Sasieni P. Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis. Ann Oncol. 2015;26:848–64. doi:10.1093/annonc/mdu525.
Lowrance WT, Elkin EB, Jacks LM, et al. Comparative effectiveness of surgical treatments for prostate cancer: a population-based analysis of postoperative outcomes. J Urol. 2010;183:1366–72. doi:10.1016/j.juro.2009.12.021.Comparative.
Lundin M, Lundin J, Burke HB, et al. Artificial neural networks applied to survival prediction in breast cancer. Oncology. 1999;57:281–6.
Mayr A, Hofner B, Schmid M. Boosting the discriminatory power of sparse survival models via optimization of the concordance index and stability selection. BMC Bioinform. 2016;17:288. doi:10.1186/s12859-016-1149-8.
Meads C, Ahmed I, Riley RD. A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Res Treat. 2012;132:365–77. doi:10.1007/s10549-011-1818-2.
Menéndez LÁ, de Cos Juez FJ, Lasheras SF, Riesgo JAÁ. Artificial neural networks applied to cancer detection in a breast screening programme. Math Comput Model. 2010;52:983–91. doi:10.1016/j.mcm.2010.03.019.
Morgan JN, Sonquist JA. Problems in the analysis of survey data, and a proposal. J Am Stat Assoc. 1963;58:415–34. doi:10.1080/01621459.1963.10500855.
Oberije C, De Ruysscher D, Houben R, et al. A validated prediction model for overall survival from stage III non-small cell lung cancer: toward survival prediction for individual patients. Int J Radiat Oncol Biol Phys. 2015;92:935–44. doi:10.1016/j.ijrobp.2015.02.048.
Parks CM. Prognoses should be based on proved indicators not intuition. BMJ. 2000;320:473. doi:10.1136/bmj.320.7233.469.
Penciana MJ, D’Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23:2109–23. doi:10.1002/sim.1802.
Pölsterl S, Conjeti S, Navab N, Katouzian A. Survival analysis for high-dimensional, heterogeneous medical data: exploring feature extraction as an alternative to feature selection. Artif Intell Med. 2016;72:1–11. doi:10.1016/j.artmed.2016.07.004.
Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Stat Med. 2004;23:723–48. doi:10.1002/sim.1621.
Saritas I. Prediction of breast cancer using artificial neural networks. J Med Syst. 2012;36:2901–7. doi:10.1007/s10916-011-9768-0.
Sauerbrei W, Hübner K, Schmoor C, Schumacher M. Validation of existing and development of new prognostic classification schemes in node negative breast cancer. Breast Cancer Res Treat. 1997;42:149–63.
Schapire RE, Freund Y. Boosting—foundations and algorithms. Cambridge: MIT Press; 2012.
Schoop R, Graf E, Schumacher M. Quantifying the predictive performance of prognostic models for censored survival data with time-dependent covariates. Biometrics. 2008;64:603–10. doi:10.1111/j.l541-0420.2007.00889.x.
Schwarzer G, Vach W, Schumacher M. On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. Stat Med. 2000;19:541–61. doi:10.1002/(SICI)1097-0258(20000229)19:4<541:AID-SIM355>3.0.CO;2-V.
Scutari M, Denis J-B. Bayesian networks: with examples in R. Boca Raton: CRC Press; 2014.
Sesen MB, Nicholson AE, Banares-Alcantara R, et al. Bayesian networks for clinical decision support in lung cancer care. PLoS ONE. 2013;8:e82349. doi:10.1371/journal.pone.0082349.
Shivaswamy PK, Chu W, Jansche M. A support vector approach to censored targets. In: Seventh IEEE international conference on data mining. New York: IEEE; 2007. p. 655–660.
Steyerberg EW, Harrell FE, Borsboom GJJM, et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54:774–81. doi:10.1016/S0895-4356(01)00341-9.
Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for some traditional and novel measures. Epidemiology. 2010;21:128–38. doi:10.1097/EDE.0b013e3181c30fb2.Assessing.
Sweilam NH, Tharwat AA, Moniem NKA. Support vector machine for diagnosis cancer disease: a comparative study. Egypt Inform J. 2010;11:81–92. doi:10.1016/j.eij.2010.10.005.
Van Belle V, Pelckmans K, Van Huffel S, Suykens JAK. Support vector methods for survival analysis: A comparison between ranking and regression approaches. Artif Intell Med. 2011;53:107–18.
van Gerven MAJ, Taal BG, Lucas PJF. Dynamic Bayesian networks as prognostic models for clinical patient management. J Biomed Inform. 2008;41:515–29. doi:10.1016/j.jbi.2008.01.006.
van Stiphout RGPM, Postma EO, Valentini V, Lambin P. The contribution of machine learning to predicting cancer outcome. Artif Intell. 2010;350:400.
Vapnik VN. Statistical learning theory. New york: Wiley Interscience; 1998.
Wang SJ, Wissel AR, Luh JY, et al. An interactive tool for individualized estimation of conditional survival in rectal cancer. Ann Surg Oncol. 2011;18:1547–52. doi:10.1245/s10434-010-1512-3.
Williams TGS, Cubiella J, Griffin SJ, et al. Risk prediction models for colorectal cancer in people with symptoms: a systematic review. BMC Gastroenterol. 2016;16:63. doi:10.1186/s12876-016-0475-7.
Yosefian I, Mosa Farkhani E, Baneshi MR. Application of random forest survival models to increase generalizability of decision trees: a case study in acute myocardial infarction. Comput Math Methods Med. 2015;2015:576413. doi:10.1155/2015/576413.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Chen, Y., Millar, J.A. (2017). Machine Learning Techniques in Cancer Prognostic Modeling and Performance Assessment. In: Matsui, S., Crowley, J. (eds) Frontiers of Biostatistical Methods and Applications in Clinical Oncology. Springer, Singapore. https://doi.org/10.1007/978-981-10-0126-0_13
Download citation
DOI: https://doi.org/10.1007/978-981-10-0126-0_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-0124-6
Online ISBN: 978-981-10-0126-0
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)